HEALTH
- Share via
Corning Begins Tender Offer for Damon: The deal, valued at about $575 million, covers all outstanding common shares of health care laboratory company Damon Corp. Damon said a week ago that Corning’s proposal to acquire it for $23 a share was superior to a previously announced $16-a-share agreement with National Health Laboratories Inc. La Jolla-based National Health said Wednesday that it dropped its bid. Damon shares closed at $22.625 on the New York Stock Exchange, up 12.5 cents. Corning said the tender offer requires a minimum of 8.9 million Damon shares, or 51%, conditioned on expiration of the regulatory antitrust waiting period, and expires Aug. 3.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.